Acute Promyelocytic Leukemia clinical trials

Explore recruiting acute promyelocytic leukemia clinical trials.

Recruiting acute promyelocytic leukemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Promyelocytic Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia

Netherlands, Italy, Sweden, Czechia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Pivotal Open-label Phase 3 Clinical Study Evaluating the Efficacy and Safety of QTX-2101 in Combination With All-trans Retinoic Acid in Newly Diagnosed, Low-risk Acute Promyelocytic Leukemia

Germany, Poland, Spain, Romania, Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Promyelocytic Leukemia trials by city

Acute Promyelocytic Leukemia clinical trials

Recruiting acute promyelocytic leukemia studies right now

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia

Frontline Oral Arsenic Trioxide for APL

Also recruiting in Europe

ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia

A Pivotal Open-label Phase 3 Clinical Study Evaluating the Efficacy and Safety of QTX-2101 in Combination With All-trans Retinoic Acid in Newly Diagnosed, Low-risk Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia trials by city

Other conditions